Auranofin-Reference-Cited by-同舟云学术

Auranofin

Published:1984-08 Issue:2 Volume:10 Page:369-383
ISSN:0307-742X
Container-title:Clinics in Rheumatic Diseases
language:en
Short-container-title:Clinics in Rheumatic Diseases

Author:

Davis Paul

Publisher

Elsevier BV

Subject

Rheumatology

Reference49 articles.

1. Oral gold therapy with auranofin (SK&F 39162), a multicentre open study in patients with rheumatoid arthritis;Bandilla;Journal of Rheumatology,1982

2. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report;Barraclough;Journal of Rheumatology,1982

3. Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis;Berglöf;Journal of Rheumatology,1978

4. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose;Bernhard;Journal of Rheumatology,1982

5. Single dose pharmacokinetics of auranofin in rheumatoid arthritis;Blocka;Journal of Rheumatology,1982

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Evaluation of a Stable Monomeric Gold(II) Complex with Hematoporphyrin IX: Cytotoxicity against Tumor and Kidney Cells, Cellular Accumulation, and Induction of Apoptosis;Bioinorganic Chemistry and Applications;2008

2. Development of a Method for the Quantification of the Molar Gold Concentration in Tumour Cells Exposed to Gold-Containing Drugs;ChemMedChem;2007-05-14

3. Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin;Clinical Rheumatology;1994-03

4. Systemic gold therapy;Clinics in Dermatology;1991-10

5. Role for zinc in a cellular response mediated by protein kinase C in human B lymphocytes;Experimental Cell Research;1991-07